Scientific and Production Association ‘Microgen’ is the largest Russian developer and manufacturer of immunobiological products
About the company
The client sought to secure its production of the live influenza vaccine at the manufacturing site in the Irkutsk Region.
Client’s request
Our results:
The client’s request was fulfilled.
01
Our solution
Key focus areas
01
In response to client’s request, we developed a GR strategy aiming at modernizing the production site by engaging public support and safeguarding public procurement of the live influenza vaccine with the Federal Agency for State Reserves (Rosrezerv).
Developing GR Strategy
02
The project involved building a meaningful dialogue with key stakeholders, including the Ministry of Health of the Russian Federation, the Ministry of Industry and Trade of the Russian Federation, the Federal Service for Surveillance on Consumer Rights Protection and Human Well-being (Rospotrebnadzor), dedicated research institutions, etc.
Industries: #Pharmaceuticals and medical devices #Healthcare #Public sector
Stakeholders:#Ministry of Health of the Russian Federation #Ministry of Industry and Trade of the Russian Federation #Federal Service for Surveillance on Consumer Rights Protection and Human Well-being (Rospotrebnadzor) #Ministry of Finance of the Russian Federation #The Government of the Russian Federation #Research and expert organizations #State Duma #FMBA of the Russian Federation #Rostec
Our toolkit: #Stakeholder mapping #Regulatory and legal analytics #GR communication #GR consulting #Organization of meetings #GR strategy #Argumentation and positioning #Lobbying #Data collection #Pharmacoeconomics #Crisis management #Coalitions and alliances #PR and media #Task forces